For patients who are tolerating the maximal therapeutic dose of a once-daily or twice-daily GLP-1 receptor agonist (exenatide 10 g twice daily, liraglutide 1.8 mg once daily, or lixisenatide 20 mg once daily) but who are changing to a once-weekly GLP-1 receptor agonist, we recommend starting dulaglutide once weekly or exenatide once weekly at the maximal therapeutic dose (dulaglutide 1.5 mg, exenatide 2 mg)
Affects metabolism and energy use Shapes appetite and fullness signals Influences fat storage and distribution Metabolic Factor Metabolism, hormones, and the gut microbiome work together to regulate body weight in ways most patients never see
These products are typically supplied in lyophilized (freeze-dried) powder form , with notable differences between sellers in terms of testing transparency, documentation, and overall quality signals
These options also support the reduced appetite that GLP-1 therapy creates, allowing smaller, nutrient-dense meals that sustain satiety longer
Check out our Essential Support Membership , which gives you access to guides, coaching support and education to equip you with knowledge to both prevent and manage acute illnesses effectively